Sciomics‘ Impact on Proteomic Research

Patents

Please find below selected patents with contribution of our scioDiscover microarray platform. 

Selected Patents 

  • WO2021175863A1: Method for diagnosis and/or prognosis of liver disease progression and risk of hepatocellular carcinoma and discovery of therapeutic compounds and targets to treat liver disease and cancer
  • WO2021162554A1: Means and methods for determining mesenchymal stromal cell properties.
  • US20210137912A1: s)-2-(1-(5-(cyclohexylcarbamoyl)-6-(propylthio)pyridin-2-yl)piperidin-3-yl)acetic acid for use in medicine
  • EP2536844B1US9551035B2: Means and methods for diagnosing pancreatic cancer
  • EP2718720B1US9678075B2: Prediction of recurrence for bladder cancer by a protein signature in tissue samples

Subcategories

  • Proteomics Research Blog

    At Sciomics, we are dedicated to advancing healthcare through proteomics research. We are collaborating with research groups and big pharma, alongside our in-house biomarker research initiatives. To make this research more accessible to you, we have launched the Sciomics science blog!

  • Publications

    Find peer-reviewed scientific publications on biomedical studies supported by our antibody microarray platform, scientific publications on the platform itself, information on poster presentations at international conferences and patents supported by Sciomics services.